Treat liver to beat diabetes

Area of Science:

• Endocrinology
• Metabolic Diseases
• Hepatology

Background:

• Type 2 Diabetes Mellitus (T2DM) management using lifestyle and pharmaceuticals has yielded limited success, with disease progression often uncontrolled.
• The liver and pancreas, both endodermal derivatives with a common precursor, are central to T2DM pathophysiology.
• Dysregulation of key metabolic pathways like glycolysis, gluconeogenesis, and glycogenolysis contributes to hyperglycemia, even with elevated insulin levels.

Purpose of the Study:

• To investigate the hypothesis that restoring abnormal liver function can improve glycemic control in Type 2 Diabetes Mellitus.
• To explore the potential of liver-centric interventions for T2DM management.

Main Methods:

• Review of existing literature on T2DM pathophysiology, liver-pancreas interactions, and the effects of liver interventions.
• Analysis of evidence suggesting shared regenerative factors between liver and pancreas.
• Examination of studies linking abnormal liver function to metabolic syndrome and T2DM development.

Main Results:

• Abnormal liver function is implicated in the development of metabolic syndrome and T2DM.
• Partial hepatectomy has demonstrated improved glycemic status in animal models of diabetes.
• Evidence suggests impaired pancreatic beta-cell function and survival, along with insulin resistance, may stem from compromised liver status.

Conclusions:

• Restoring deranged liver functions may offer a novel therapeutic strategy for better Type 2 Diabetes Mellitus control.
• This approach could potentially shift T2DM treatment focus from the pancreas towards the liver.